High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation

BACKGROUND: Guidelines regarding treatment for autoimmune hepatitis (AIH) favour two strategies for azathioprine (AZA) introduction: concurrent with steroids at induction or delayed by 2‐4 weeks. The safety and efficacy of both strategies have been unexplored. METHODS: We established a cohort of 900...

Descripción completa

Detalles Bibliográficos
Autores principales: Pape, Simon, Gevers, Tom J. G., Vrolijk, Jan Maarten, van Hoek, Bart, Bouma, Gerd, van Nieuwkerk, Carin M. J., Taubert, Richard, Jaeckel, Elmar, Manns, Michael P., Papp, Maria, Sipeki, Nora, Stickel, Felix, Efe, Cumali, Ozaslan, Ersan, Purnak, Tugrul, Nevens, Frederik, Kessener, Dominik J. N., Kahraman, Alisan, Wedemeyer, Heiner, Hartl, Johannes, Schramm, Christoph, Lohse, Ansgar W., Heneghan, Michael A., Drenth, Joost P. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Gut‐liver Axis, Immunology, Immune Mediated and Cholestatic Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496382/
https://www.ncbi.nlm.nih.gov/pubmed/32410363
http://dx.doi.org/10.1111/liv.14513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496382/
https://www.ncbi.nlm.nih.gov/pubmed/32410363
http://dx.doi.org/10.1111/liv.14513

Ejemplares similares